|
Atomistry » Chlorine » PDB 7sr6-7t48 » 7szq | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 7sr6-7t48 » 7szq » |
Chlorine in PDB 7szq: Human P300 Complexed with An Azaindazole InhibitorEnzymatic activity of Human P300 Complexed with An Azaindazole Inhibitor
All present enzymatic activity of Human P300 Complexed with An Azaindazole Inhibitor:
2.3.1.48; Protein crystallography data
The structure of Human P300 Complexed with An Azaindazole Inhibitor, PDB code: 7szq
was solved by
L.M.Shewchuk,
R.A.Reid,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Human P300 Complexed with An Azaindazole Inhibitor
(pdb code 7szq). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Human P300 Complexed with An Azaindazole Inhibitor, PDB code: 7szq: Chlorine binding site 1 out of 1 in 7szqGo back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Human P300 Complexed with An Azaindazole Inhibitor
![]() Mono view ![]() Stereo pair view
Reference:
X.Tian,
D.Suarez,
D.Thomson,
W.Li,
E.A.King,
L.Lafrance,
J.Boehm,
L.Barton,
C.Di Marco,
C.Martyr,
R.Thalji,
J.Medina,
S.Knight,
D.Heerding,
E.Gao,
E.Nartey,
T.Cecconie,
C.Nixon,
G.Zhang,
T.J.Berrodin,
C.Phelps,
A.Patel,
X.Bai,
K.Lind,
N.Prabhu,
J.Messer,
Z.Zhu,
L.Shewchuk,
R.Reid,
A.P.Graves,
C.Mchugh,
B.Mangatt.
Discovery of Proline-Based P300/Cbp Inhibitors Using Dna-Encoded Library Technology in Combination with High-Throughput Screening. J.Med.Chem. V. 65 14391 2022.
Page generated: Sun Jul 13 07:16:16 2025
ISSN: ISSN 0022-2623 PubMed: 36302181 DOI: 10.1021/ACS.JMEDCHEM.2C00670 |
Last articlesMg in 3T2CMg in 3T2B Mg in 3T1R Mg in 3T1O Mg in 3T0D Mg in 3T1Q Mg in 3T12 Mg in 3T1K Mg in 3T10 Mg in 3T0Z |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |